Results 121 to 130 of about 45,242 (261)
Descrevem-se dois surtos de tripanossomíase por Trypanosoma vivax em bovinos, ocorridos em dois estabelecimentos do alto sertão da Paraíba. Os sinais clínicos, a patologia e a epidemiologia da doença foram estudados no período de maio de 2005 a novembro ...
Jael S. Batista +6 more
doaj +1 more source
Human African trypanosomiasis control: Achievements and challenges
Sleeping sickness, also known as human African trypanosomiasis (HAT), is a neglected disease that impacts 70 million people living in 1.55 million km2 in sub-Saharan Africa.
S. Aksoy +4 more
semanticscholar +1 more source
Estimates of the duration of the early and late stage of gambiense sleeping sickness [PDF]
Background: The durations of untreated stage 1 (early stage, haemo-lymphatic) and stage 2 (late stage, meningo-encephalitic) human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense are poorly quantified, but key to ...
Filipe, João AN +26 more
core +4 more sources
Five adult donkeys were experimentally infected with Brazilian strain of Trypanosoma evansi originally isolated from a naturally infected dog to study the hematological biochemical and histopathological alterations during the evolution of the disease ...
F.A. Cadioli +5 more
doaj +1 more source
The Long Wait for a New Drug for Human African Trypanosomiasis.
Human African trypanosomiasis (HAT) is responsible for around 3000 reported cases each year. Treatments for HAT are expensive and problematic to administer, and available drugs are old and less than ideal, some with high levels of toxicity that result in
C. H. Baker, S. Welburn
semanticscholar +1 more source
Human African trypanosomiasis (HAT) and African animal trypanosomosis (AAT) are devastating diseases spread by tsetse flies (Glossina spp.), affecting humans and livestock, respectively.
Mirieri Caroline K. +7 more
doaj +1 more source
Computer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors : toward the development of novel therapies for African sleeping sickness [PDF]
Trypanosoma brucei, the causative agent of human African trypanosomiasis, affects tens of thousands of sub-Saharan Africans. As current therapeutics are inadequate due to toxic side effects, drug resistance, and limited effectiveness, novel therapies are
Durrant, Jacob D. +3 more
core +3 more sources
Folk medicine is widely used in Angola, even for human African trypanosomiasis (sleeping sickness) in spite of the fact that the reference treatment is available for free.
Nina Vahekeni +13 more
doaj +1 more source
African trypanosomiasis gambiense, Italy
African trypanosomiasis caused by Trypanosoma brucei gambiense has not been reported in Italy. We report 2 cases diagnosed in the summer of 2004. Theses cases suggest an increased risk for expatriates working in trypanosomiasis-endemic countries.
Pierluigi Viale +23 more
core +1 more source
Background Important control efforts have led to a significant reduction of the prevalence of human African trypanosomiasis (HAT) in Côte d’Ivoire, but the disease is still present in several foci.
M. N'Djetchi +15 more
semanticscholar +1 more source

